Halberd

Halberd EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Halberd (HALB) as of Oct 11, 2026 is -15.88. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -4.02 — a change of 294.77% (lower).

EV/FCF

-15.88

YoY

294.77%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Halberd is 2024 -15.88 . EV/FCF (Enterprise Value to Free Cash Flow) of Halberd was 2023 -4.02 . It decreases by 294.77% lower compared to the previous year.

The Halberd EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2017
-1,256.31 USD
Jan 1, 2018
-137,566.67 USD
Jan 1, 2019
-37.66 USD
Jan 1, 2020
-18.78 USD
Jan 1, 2021
-1.21 USD
Jan 1, 2022
-1.05 USD
Jan 1, 2023
-4.02 USD
Jan 1, 2024
-15.88 USD
The Halberd EV/FCF history
YEAREV/FCFYoY
-15.88+294.77%
-4.02+284.94%
-1.05-13.76%
-1.21-93.55%
-18.78-50.14%
-37.66-99.97%
-137,566.67+10,850.08%
-1,256.31-74.94%
-5,013.23—
Access this data via the Eulerpool API

Halberd Stock analysis

What does Halberd do? The Halberd Corp is an American company founded in 1987 and based in New York. It is a high-tech company focused on the development of medical technologies. Since its inception, the company has developed numerous innovative products and technologies that are used worldwide. A significant portion of Halberd Corp's business model focuses on providing medical products and solutions for various diseases. The main divisions of the company are biotechnology and pharmaceuticals, medical respiratory protection, medical technology, and the development of antibodies and diagnostics. Some of the most well-known products of Halberd Corp are the Medical Respiratory Masks, which were of great importance during the COVID-19 pandemic. These masks were developed and distributed worldwide by the company with innovative technology and the highest quality standards. The company has also developed various medical devices such as infusion pumps, blood pressure monitors, and various diagnostic devices that have been used by hospitals and care facilities. Another important business area of Halberd Corp is biotechnology and pharmaceuticals. In this field, the company specializes in developing new drugs and therapies for various diseases. The company has developed a range of proprietary medications that are used in the treatment of various diseases. Halberd Corp is also known for its development of antibodies and diagnostics and offers corresponding test kits. In recent years, Halberd Corp has formed numerous partnerships with other companies and institutions to bring its innovations to the market and market them. The company is also known for its successful joint ventures with other companies in the healthcare sector. Overall, Halberd Corp is an innovative company focused on medical technologies. With its presence in various areas of the healthcare industry, the company is able to develop new products and solutions that have the potential to improve and save lives. Halberd is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Halberd stock

EV/FCF (Enterprise Value to Free Cash Flow) of Halberd is -15.88 in 2024.

EV/FCF (Enterprise Value to Free Cash Flow) of Halberd changed from -4.02 to -15.88, representing a 294.77% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Halberd since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Halberd with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Halberd

All Key Metrics — Halberd